WHO ICTRP trial
Comparison of conventional quadruple therapy and high-dose dual therapy for HP…
ChiCTR2200056895 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200056895 |
|---|---|
| Public title | Comparison of conventional quadruple therapy and high-dose dual therapy for HP eradication |
| Scientific title | Comparison of conventional quadruple therapy and high-dose dual therapy for HP eradication |
| Primary sponsor | Third People's Hospital of Jingdezhen |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Helicobacter pylori infection |
| Interventions | Group 1:Conventional quadruple therapy;Group 2:High-dose dual therapy |
| Registration date | Feb 22, 2022 |
| Target size | Group 1:157;Group 2:157 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: